Senseonics (NYSE:SENS) announced that its chief financial officer, Nick Tressler, is transitioning from his position. Tressler’s transition is effective as of yesterday, Sept. 1, 2022. Senseonics selected VP of Finance, Rick Sullivan, to succeed Tressler as CFO. Get the full story at our sister site, Drug Delivery Business News.
Patient Monitoring
Study backs next-gen Medtronic MiniMed 780G insulin pump
Medtronic (NYSE:MDT) today announced positive results from a study of its next-generation MiniMed 780G automated insulin delivery system. Results from the ADAPT study, published in The Lancet Diabetes & Endocrinology, demonstrated improved glycemic control and treatment satisfaction among users of MiniMed 780G. The MiniMed 780G system is available in more than 60 countries. It is currently […]
Integra’s CereLink ICP Monitor recall is Class I
The FDA has labeled the recall of the Integra LifeSciences (Nasdaq:IART) CereLink system as Class I, the most serious kind. Integra designed its CereLink system for intracranial pressure (ICP) monitoring. Last week, the company announced an immediate, voluntary global product removal of the systems. An FDA notice classified the U.S. recall, initiated by Integra on […]
Dexcom names Jake Leach chief operating officer
Dexcom (Nasdaq:DXCM) announced that it promoted chief technology officer Jake Leach to the chief operating officer (COO) role. Leach served as CTO since 2018, leading the company’s research, product development, product management and engineering departments. He joined the company in 2004 to lead the development of sensor electronics for its first commercial continuous glucose monitor […]
Masimo launches health-tracking watch for consumers
Masimo (Nasdaq:MASI) announced today that it began the full market release of its Masimo W1 health watch for consumer use. Irvine, California-based Masimo designed its W1 watch to offer accurate, continuous measurements and insightful health data. The wrist-worn wearable builds on the company’s personal, lifestyle-friendly designs for non-invasive blood parameter monitoring. For the first time […]
Medtronic, BioIntelliSense partner on distribution of wearable patient monitoring device
Medtronic (NYSE:MDT) announced today that it partnered with BioIntelliSense on distribution rights for the BioButton device. BioButton, a multi-paremter wearable for continuous, connected monitoring, measures up to 1,440 vital sign measurements per day. Its measurements include skin temperature, respiratory rate at rest, and heart rate at rest. The device, combined with advanced analytics, helps clinicians […]
Philips to pay $4.2M in DOJ settlement over patient monitoring device modifications
Philips (NYSE:PHG) today agreed to pay approximately $4.2 million to resolve allegations of substituting key components of a monitoring device. The company settled with the U.S. Department of Justice over claims that it substituted the components of its Intellivue MP2 mobile patient monitoring device that it sold to military purchasers without rectifying the device for […]
Study shows workplace productivity improvements with One Drop type 2 diabetes tech
One Drop today announced positive results from a trial of its digital health platform for people with type 2 diabetes. Employees using the One Drop digital diabetes management platform experienced significant productivity and functioning gains and were less likely to experience presenteeism at follow-up compared to control groups. Get the full story at our sister site, […]
Fitbit unveils fall lineup that includes AFib-detecting smartwatch
Google’s Fitbit has announced its upcoming releases this fall, with one health-focused offering providing heart health tracking capabilities. According to a blog post presenting the new offerings, the new Inspire 3, Versa 4 and Sense 2 — the latter of which being the heart health tracker — are all thinner and more comfortable than previous […]
Integra Lifesciences voluntarily recalls CereLink intracranial pressure monitors
Integra LifeSciences (Nasdaq:IART) announced today that it initiated an immediate, voluntary global product removal of CereLink. The company on Aug. 18, 2022, initiated the product removal of all CereLink intracranial pressure monitors as a result of customer reports about monitors whose pressure readings were out of range. According to a news release, Integra believes that […]
Glytec, CPS collaborate on glycemic management support for pharmacy departments
Glytec announced today that CPS Solutions selected it to serve as an insulin management technology resource. Waltham, Massachusetts-based Glytec will serve as a resource for CPS’ more than 2,200 pharmacy professionals across more than 800 healthcare facilities nationwide. Get the full story at our sister site, Drug Delivery Business News.